Clotting complications of L-asparaginase therapy in children with ALL.
Cappellato
M G
MG
Rosolen
A
A
Zanesco
L
L
Girolami
A
A
D000347:Afibrinogenemia / Q000139:chemically induced*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D020152:Antithrombin III Deficiency; D001215:Asparaginase / Q000008:administration & dosage / Q000009:adverse effects*; D001778:Blood Coagulation Disorders / Q000139:chemically induced*; D002648:Child; D006801:Humans; D007945:Leukemia, Lymphoid / Q000097:blood* / Q000188:drug therapy
D001215:Asparaginase